Bvf Inc Inventiva S.A. Call Options Transaction History
Bvf Inc
- $2.28 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding IVA
# of Institutions
8Shares Held
4.86MCall Options Held
0Put Options Held
0-
Yiheng Capital Management, L.P. San Francisco, CA2.64MShares$9.39 Million0.76% of portfolio
-
Nea Management Company, LLC Timonium, MD1.46MShares$5.19 Million0.41% of portfolio
-
Commonwealth Equity Services, LLC54.5KShares$193,4250.0% of portfolio
-
Wealth Enhancement Advisory Services, LLC10.7KShares$38,0380.0% of portfolio
-
Ubs Group Ag708Shares$2,5130.0% of portfolio
About Inventiva S.A.
- Ticker IVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,134,200
- Market Cap $150M
- Description
- Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS), and other diseases. Its lead product candidate is Lanifibranor, which has completed Phase IIb clinical trial to treat NASH. The company als...